FDA Panel Urges More Studies of Stroke Med
14666
A US advisory panel on Friday recommended against approving AstraZeneca&#39;s new stroke prevention medication, Exanta, citing concerns about the drug&#39;s effect on the liver.
77653
A US advisory panel on Friday will review data on an experimental drug that is injected into the eye to stop vision loss in elderly patients at risk of going blind.
379737
Federal advisers who met last week to consider whether to restrict doses of popular antianemia drugs were themselves under scrutiny during the hearing. The Food and Drug Administration is considering a top-to-bottom reshaping of how it picks and uses the outside scientists who serve on the agency's advisory panels.
564989
A blood-thinning drug not approved for the U.S. market because of questions about liver damage appears to be as effective as other common therapies for preventing strokes and recurring blood clots, according to studies published on Tuesday.
471291
CHICAGO - The American Medical Association called for more research into the public health risks of video and Internet games on Wednesday but stopped short of declaring them addictive.
458921
Congress is looking into whether the Food and Drug Administration ignored safety concerns about the drug raised by its own reviewers and outside scientists.
261809
Faced with pressure from lawmakers and editors of medical journals, four trade groups representing the world's biggest drug makers said yesterday that their members planned to release more data about clinical drug trials.
268363
GAITHERSBURG, Maryland  - The Food and Drug Administration should consider telling patients and doctors that the use of drug-coated heart stents in unapproved, high-risk cases can lead to greater complications, a panel of medical experts said on Friday.
265165
A second Food and Drug Administration advisory committee agreed that healthy children as young as 9 could be given the stimulant dextroamphetamine in an experiment, concurring with an ethics panel&#39;s recommendation last week.
339005
A U.S. advisory panel on Friday will review data on an experimental drug that is injected into the eye to stop vision loss in elderly patients at risk of going blind.
457614
One of the nation&#39;s leading cardiovascular medical researchers has issued a call for less aggressive direct-to-consumer advertising and better safety assurances of medications in a special article posted online today by JAMA because of its relevance to
35834
The Food and Drug Administration needs more staff, funding and authority over the drug industry to better track the safety of medicines after they reach the market, an Institute of Medicine report said Friday.
468107
Prompted by results of two previous studies, physicians today warn breast cancer patients who take tamoxifen that the drug might increase their stroke risk-but a new study by Southern California researchers finds no link between tamoxifen and stroke.
19437
Recent studies have suggested that Celebrex and Bextra may increase the risk of heart attack and stroke.
393322
MONDAY, Oct. 11 (HealthDayNews) -- The breast cancer drug tamoxifen may cause a slight increase in stroke risk, says a Duke University Medical Center study in the Oct. 12 issue of Neurology.
454410
Editors of the world&#39;s leading medical journals said yesterday that drug companies should disclose more information about studies of new medicines.
733605
U.S. health officials said on Friday they would review whether to take regulatory action over Merck & Co Inc  and Schering-Plough's  cholesterol medicine Vytorin following the drug's failure to work better than a generic drug in a study of plaque build-up in neck arteries.